Outcomes in Patients with Myelofibrosis: Pacritinib Vs BAT in the Phase III Persist-1 Trial
At ASH 2015, Dr. Alessandro Vannucci from the University of Florence discussed his abstract titled "Analysis of Outcomes By Patient Subgroups in Patients with Myelofibrosis Treated with Pacritinib Vs Best Available Therapy (BAT) in the Phase III Persist-1 Trial."
Recent Video
Most Popular
Specialties :                    Search :

MPNUniversity.tv is a member of the Oncology.TV family of oncology medical education websites. MPNUniversity.tv offers specialists, primary care physicians, and other healthcare professionals the timeliest comprehensive and relevant clinical information to improve patient care. We provide medical education (both free CE and non CE, including interactive case based presentations), news and information about Myeloproliferative Neoplasms (MPNs).